These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Individualizing care with injectable glucose-lowering agents.
    Author: Miller EM.
    Journal: J Fam Pract; 2013 Dec; 62(12 Suppl CME):S12-9. PubMed ID: 24340344.
    Abstract:
    Insulin and GLP-1R agonists are important treatment options for the management of patients with T2DM, yet provider and patient concerns limit their use. Effective strategies, including ongoing patient education, can be easily implemented to overcome concerns and streamline initiation and ongoing use of injectables. The use of a GLP-1R agonist, for example, is 1 strategy recommended when avoidance of hypoglycemia or weight gain is a specific treatment goal.
    [Abstract] [Full Text] [Related] [New Search]